Final analysis of serum biomarkers in patients (pts) from the phase III study of lenvatinib (LEN) vs sorafenib (SOR) in unresectable hepatocellular carcinoma (uHCC) [REFLECT]

Authors :: Yasuhiro Funahashi
A-L Cheng
Fabio Piscaglia
Masafumi Ikeda
T.R.J. Evans
Min Ren
Roger K.C. Ngan
Shukui Qin
Arndt Vogel
Lucjan Wyrwicz
Masatoshi Kudo
Yukinori Minoshima
Toshiyuki Tamai
J.-F. Blanc
Richard S. Finn
Michio Kanekiyo
R. Dairiki
Corina E. Dutcus
A. Baron
K.-H. Han
Source :: Annals of Oncology. 29:viii17-viii18
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Full Text Access

Tools